🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Determinants of Physical Frailty in Parkinson's Disease: A Multi-Factorial Analysis

Recruitingn/aAges 40 Years - 85 YearsAllAcibadem University
NCT07488364 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of this study is to examine the associations between motor imagery capacity, body awareness (interoceptive awareness), kinesiophobia, physical activity level, and symptom severity in individuals with Parkinson's disease. In addition, the study aims to evaluate the relationships between these variables and physical frailty. This cross-sectional observational study will provide insight into the biopsychosocial factors associated with frailty in Parkinson's disease.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Clinically diagnosed Parkinson's disease * Hoehn and Yahr stage 1-3 * Age 40 to 85 years * Mini-Mental State Examination (MMSE) score ≥24 * Attending the Movement Disorders Outpatient Clinic, Department of Neurology * Able to understand the study procedures and provide written informed consent Exclusion Criteria: * Major depressive disorder or psychotic disorder * Advanced dementia * Severe cardiovascular or respiratory disease * Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension) * Additional neurological or orthopedic conditions that may affect assessment performance * Severe visual or hearing impairment that could interfere with study assessments * Inability to cooperate with the physiotherapist during study assessments
💊

What it tests

  • Observational Questionnaire and Functional Assessment
📍

Where

1 site
Acibadem University
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy